Be A Freedom Fighter · Bill Library

S 3258 — Aviation Medication Transparency Act of 2026

Freedom score: +1 (scale −10 to +10)

Sponsor: Sen. Duckworth, Tammy [D-IL] · Latest action: Held at the desk. (2026-10-01)

Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index

Findings — 4 highlighted provisions

Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.

  1. Sec. 2(a) · Privacy and Due Process — Operative effect: Purpose — ensure aviation stakeholders (airmen, air traffic control specialists and trainees) who are applicants for medical certification or clearance are informed in a user-friendly and accessible manner about (1) medications on the "Do Not Issue" and "Do Not Fly" lists and (2) medications they may safely purchase over the counter or be prescribed See in text ↓
  2. Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice See in text ↓
  3. Sec. 2(d) · Privacy and Due Process — Operative effect: The list shall be updated not later than 1 year after publication and when the Guide for Aviation Medical Examiners is updated See in text ↓
  4. Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance See in text ↓

Full text (introduced version)

14 of 15 text blocks highlighted. Source: GovInfo, fetched cached.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 3258 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 3258 To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen and air traffic control specialists, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES November 20, 2025 Ms. Duckworth (for herself, Mr. Hoeven, Mr. Durbin, and Mrs. Britt) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation _______________________________________________________________________ A BILL To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen and air traffic control specialists, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Aviation Medication Transparency Act of 2025''.

SEC. 2. AVIATION MEDICATION TRANSPARENCY; LIST OF APPROVED MEDICATIONS.

Sec. 2(a) · Privacy and Due Process — Operative effect: Purpose — ensure aviation stakeholders (airmen, air traffic control specialists and trainees) who are applicants for medical certification or clearance are informed in a user-friendly and accessible manner about (1) medications on the "Do Not Issue" and "Do Not Fly" lists and (2) medications they may safely purchase over the counter or be prescribed

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(a) Purpose.--The purpose of this Act is to ensure that aviation stakeholders, including airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists, who are applicants for medical certification are informed, in a user-friendly and accessible manner, of the medications they may be safely prescribed.

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(b) In General.--Not later than 1 year after the date of enactment of this Act, the Administrator of the Federal Aviation Administration (in this section referred to as the ``Administrator'') shall publish and maintain on a publicly available website of the Federal Aviation Administration (in this section referred to as the ``FAA'') a list of medications that the Administrator, as of the date of publication, has--

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(1) determined may be safely prescribed to an applicant for medical certification to treat certain medical conditions; and

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(2) approved for purposes of the issuance of a medical certification to an airman or air traffic control specialist.

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(c) Requirements.--To ensure medical appropriateness, user- friendliness, and appropriate dissemination, the list required under subsection (b) shall--

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(1) be drafted in consultation with-- (A) the Aeromedical Innovation and Modernization Working Group (established under section 411(a) of the FAA Reauthorization Act of 2024 (49 U.S.C. 44703 note)) (in this section referred to as the ``Working Group''); (B) institutions of higher education that are accredited by the Aviation Accreditation Board International; (C) the certified exclusive bargaining representatives of air traffic controllers of the FAA certified under section 7111 of title 5, United States Code; (D) organizations representing certified collective bargaining representative of airline pilots; and (E) any other stakeholder determined relevant by the Working Group;

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(2) cover all medications approved by the Administrator, including prescription medications and over-the-counter medications;

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(3) be drafted in a user-friendly and accessible manner and provided to airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists at the time when any such individual first seeks a medical certification;

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(4) if applicable, indicate the minimum and average period of time an airman or air traffic control specialist is required to have limited or no duties to stabilize on an approved medication;

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(5) include the list of medications that the Administrator has designated as ``Do Not Issue'';

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(6) include information for doctors or medical providers to contact the FAA regarding questions related to such list, including through a new or existing mechanism that is accessible to such doctors and medical providers;

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(7) include any additional information that the Administrator determines is appropriate to provide with respect to what conditions a certain medication may or may not be used to treat, as well as any information to explain why a medication is allowed or prohibited by the FAA; and

Sec. 2(b)-(c) · Privacy and Due Process — Operative effect: The Administrator shall publish a user-friendly guide and list, publicly available and on MedXPress and given to first-time certification or clearance seekers, containing (A) medications allowed, including prescription and over-the-counter medications, (B) contraindications, (C) whether review by the FAA is required, a minimum stabilization period for limited or no duties if practicable, the list of "Do Not Issue" and "Do Not Fly" medications, information for doctors and medical providers to contact the FAA regarding the list, and other information the Administrator determines appropriate. Affected parties: airmen, air traffic control specialists, trainees and their doctors. Domain: privacy/due process (D) — fair notice

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(8) include any other information or clarification that the Administrator determines appropriate.

Sec. 2(d) · Privacy and Due Process — Operative effect: The list shall be updated not later than 1 year after publication and when the Guide for Aviation Medical Examiners is updated

Sec. 2(e) · Privacy and Due Process — Operative effect: Savings clause — publication of the list shall not be construed as assigning liability to the Administrator if an airman, air traffic control specialist or applicant relies on the list and (1) suffers an adverse reaction, (2) causes harm or injury to persons or property, or (3) is deemed ineligible for certification or clearance

(d) Annual Update.--Not later than 1 year after the date of publication of the list required under subsection (b), and annually thereafter, the Administrator shall update such list, as appropriate. <all>

Findings source: bill-scores-v2-batch14-findings-2026-11-14.md. Highlights come only from that file; no finding, score, or provision was invented for this page.

What you can do

Contact your U.S. Representative and Senators about this bill.

Find your Representative Contact your Senators

Spot an error on this page? Report it.